Sildenafil citrate by XOMA Royalty for Female Hypoactive Sexual Desire Disorder: Likelihood of Approval

Sildenafil citrate is under clinical development by XOMA Royalty and currently in Phase II for Female Hypoactive Sexual Desire Disorder.

Climate Change and Its Negative Effects on Lung Health

A session at the recent American Thoracic Society (ATS) annual meeting focused on the effect that the environment has on lung health. It included a

June 28, 2024

Fused pancreatic cancer organoid system captures tumor heterogeneity and drug resistance

Pancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial cells, is the most common form of pancreatic cancer, with a very high mortality rate.

December 8, 2023

Quick finger prick could soon make Alzheimer’s testing much more accessible

A quick finger prick and a few drops of blood on a card that can be sent in regular mail. This approach could soon make

November 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.